您当前的位置：
首页 >
文章列表页 >
Pharmacoeconomic evaluation of dual antiplatelet therapy followed by maintenance therapy with clopidogrel or aspirin after PCI
更新时间：2025-12-10

    • Pharmacoeconomic evaluation of dual antiplatelet therapy followed by maintenance therapy with clopidogrel or aspirin after PCI

    • “The latest research shows that maintenance therapy with clopidogrel monotherapy is more cost-effective than aspirin in Chinese patients undergoing percutaneous coronary intervention (PCI) after DAPT.”
    • ZHONGGUO YAOFANG   Vol. 36, Issue 23, Pages: 2952-2957(2025)

    • DOI：10.6039/j.issn.1001-0408.2025.23.12    

      CLC： R956

    • Received：05 August 2025，

      Revised：2025-11-20，

      Accepted：22 November 2025，

      Published：15 December 2025

    移动端阅览

  • LUO Bing,JIANG Yueyun,CHEN Yili.Pharmacoeconomic evaluation of dual antiplatelet therapy followed by maintenance therapy with clopidogrel or aspirin after PCI[J].ZHONGGUO YAOFANG,2025,36(23):2952-2957. DOI： 10.6039/j.issn.1001-0408.2025.23.12.

  •  
  •  

0

Views

0

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Cost-utility analysis of pembrolizumab combined with chemotherapy in the first-line treatment of advanced or unresectable biliary tract carcinoma
Pharmacoeconomic evaluation of finerenone combined with standard regimen in the treatment of heart failure with preserved or mildly reduced ejection fraction
Pharmacoeconomic evaluation of camrelizumab combined with chemotherapy in the treatment of cervical cancer in China
Cost-utility analysis of bevacizumab combined with erlotinib in the first-line treatment of advanced EGFR mutant non-squamous NSCLC
Systematic review of pharmacoeconomic evaluation on PCSK9 inhibitors for the prevention of cardiovascular disease in patients with hypercholesterolemia

Related Author

WANG Xuanhui
DING Ying
GONG Chunbo
LIANG Hai
LIU Li
ZHAO Mengmeng
DI Panpan
JIANG Mengyu

Related Institution

School of Pharmacy， Shandong University of Traditional Chinese Medicine
Dept. of Pharmacy， People’s Hospital of Bozhou
School of Public Health， Chongqing Medical University
Dept. of Pharmacy， the First Affiliated Hospital of China University of Science and Technology
Discipline Key Laboratory for Key Technology Research and Clinical Application of Mass Spectrometry Jointly Constructed by Anhui Province
0